The Impact on the Health Status and Adherence in a Real-life Setting of Italian Patients With Chronic Obstructive Pulmonary Disease in Treatment With Trimbow pMDI b.i.d.: a 12-month Prospective Observational Study
Latest Information Update: 14 Nov 2023
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms TRITRIAL
- Sponsors Chiesi Farmaceutici
Most Recent Events
- 04 May 2022 Status changed from active, no longer recruiting to completed.
- 12 Apr 2021 Planned End Date changed from 1 Aug 2021 to 1 Jan 2022.
- 12 Apr 2021 Planned primary completion date changed from 1 Aug 2021 to 1 Jan 2022.